These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36866724)

  • 1. Randomised, placebo-controlled trial and meta-analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The TRITON trial.
    Gunn D; Topan R; Barnard L; Fried R; Holloway I; Brindle R; Corsetti M; Scott M; Farmer A; Kapur K; Sanders D; Eugenicos M; Trudgill N; Whorwell P; Mclaughlin J; Akbar A; Houghton L; Dinning PG; Aziz Q; Ford AC; Farrin AJ; Spiller R
    Aliment Pharmacol Ther; 2023 Jun; 57(11):1258-1271. PubMed ID: 36866724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial.
    Gunn D; Fried R; Lalani R; Farrin A; Holloway I; Morris T; Olivier C; Kearns R; Corsetti M; Scott M; Farmer A; Emmanuel A; Whorwell P; Yiannakou Y; Sanders D; Mclaughlin J; Kapur K; Eugenicos M; Akbar A; Trudgill N; Houghton L; Dinning PG; Ford AC; Aziz Q; Spiller R
    Trials; 2019 Aug; 20(1):517. PubMed ID: 31429811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea.
    Garsed K; Chernova J; Hastings M; Lam C; Marciani L; Singh G; Henry A; Hall I; Whorwell P; Spiller R
    Gut; 2014 Oct; 63(10):1617-25. PubMed ID: 24334242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
    Videlock EJ; Cheng V; Cremonini F
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bimodal Release Ondansetron Improves Stool Consistency and Symptomatology in Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Trial.
    Plasse TF; Barton G; Davidson E; Abramson D; Kalfus I; Fathi R; Raday G; Harris MS
    Am J Gastroenterol; 2020 Sep; 115(9):1466-1473. PubMed ID: 32639235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D).
    Lam C; Tan W; Leighton M; Hastings M; Lingaya M; Falcone Y; Zhou X; Xu L; Whorwell P; Walls AF; Zaitoun A; Montgomery A; Spiller R
    Gut; 2016 Jan; 65(1):91-9. PubMed ID: 25765462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blinded randomised placebo controlled trial of enterosgel (polymethylsiloxane polyhydrate) for the treatment of IBS with diarrhoea (IBS-D).
    Howell CA; Kemppinen A; Allgar V; Dodd M; Knowles CH; McLaughlin J; Pandya P; Whorwell P; Markaryan E; Yiannakou Y
    Gut; 2022 Dec; 71(12):2430-2438. PubMed ID: 35760493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points.
    Lacy BE; Chang L; Rao SSC; Heimanson Z; Sayuk GS
    Clin Ther; 2023 Mar; 45(3):198-209. PubMed ID: 36922331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for preventing postpartum constipation.
    Turawa EB; Musekiwa A; Rohwer AC
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011625. PubMed ID: 26387487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of purified clinoptilolite-tuff treatment in patients with irritable bowel syndrome with diarrhea: Randomized controlled trial.
    Anderle K; Wolzt M; Moser G; Keip B; Peter J; Meisslitzer C; Gouya G; Freissmuth M; Tschegg C
    World J Gastroenterol; 2022 Dec; 28(46):6573-6588. PubMed ID: 36569277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of mucosal serotonin metabolism and 5-HT
    Gunn D; Garsed K; Lam C; Singh G; Lingaya M; Wahl V; Niesler B; Henry A; Hall IP; Whorwell P; Spiller R
    Aliment Pharmacol Ther; 2019 Sep; 50(5):538-546. PubMed ID: 31342534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.
    Liang SB; Han M; Cheng HJ; Zhang QY; Zhang NW; Jia BY; Robinson N; Liu JP
    Trials; 2022 Mar; 23(1):226. PubMed ID: 35313933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tegaserod for the treatment of irritable bowel syndrome.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo Response Rates in Trials of Licensed Drugs for Irritable Bowel Syndrome With Constipation or Diarrhea: Meta-analysis.
    Barberio B; Savarino EV; Black CJ; Ford AC
    Clin Gastroenterol Hepatol; 2022 May; 20(5):e923-e944. PubMed ID: 34425274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis.
    Black CJ; Burr NE; Camilleri M; Earnest DL; Quigley EM; Moayyedi P; Houghton LA; Ford AC
    Gut; 2020 Jan; 69(1):74-82. PubMed ID: 30996042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Zheng Y; Yu T; Tang Y; Xiong W; Shen X; Jiang L; Lin L
    PLoS One; 2017; 12(3):e0172846. PubMed ID: 28291778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome.
    Zhou Q; Verne ML; Fields JZ; Lefante JJ; Basra S; Salameh H; Verne GN
    Gut; 2019 Jun; 68(6):996-1002. PubMed ID: 30108163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea.
    Fukudo S; Ida M; Akiho H; Nakashima Y; Matsueda K
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):953-9.e4. PubMed ID: 24315882
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.